Our Services Medications Semaglutide Tirzepatide Wegovy Future Medications Upcoming FDA Approval triple G or Retatrutide (GLP, GIP, and CGRP injection) Orforglipron (oral GLP-1) CariSema (amylin and GLP-1 injection) MariTide (GLP-1 monthly injection) Nimacimab (MASH/MAFLD treatment) Non-Surgical Weight Loss Safe, effective alternatives to surgical weight loss Medically supervised programs tailored to your needs Personalized treatment plans using evidence-based methods Support for sustainable, long-term weight loss Nutrition & Weight Loss Guidance to improve daily food intake Strategies to balance blood sugar levels Support for building healthy eating habits Nutrition-focused plans to enhance overall health Weight Loss Management Ongoing support throughout your weight loss journey Adjustments to your medical weight loss program as needed Lifestyle coaching for sustainable results Tools to help you maintain your goal weight confidently Healthcare, the way you want it
Sports (Basel)
A phase I, double-blind clinical trial designed to evaluate the safety of a bioengineered, non-recombinant, human cellderived formulation containing follistatin, keratinocyte growth factor (KGF), and vascular endothelial growth factor (VEGF) was performed to assess the efficacy in stimulating hair growth (203)
CagriSemas side effect data from the REDEFINE and REIMAGINE programs shows GI events at rates similar to or slightly higher than semaglutide monotherapy
The pre-packaged, portion-controlled meals made planning and prep virtually effortless, and the app helped Pete track meals and stay on schedule
